Thomas Urup

855 total citations
30 papers, 585 citations indexed

About

Thomas Urup is a scholar working on Genetics, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Urup has authored 30 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 13 papers in Cancer Research and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Urup's work include Glioma Diagnosis and Treatment (26 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Thomas Urup is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Thomas Urup collaborates with scholars based in Denmark, Germany and United States. Thomas Urup's co-authors include Hans Skovgaard Poulsen, Lars Rønn Olsen, Benito Campos, Signe Regner Michaelsen, Ulrik Lassen, Helle Broholm, Kirsten Grunnet, Ib Jarle Christensen, Vibeke Andrée Larsen and Ian Law and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Thomas Urup

29 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Urup Denmark 14 366 192 171 155 120 30 585
Signe Regner Michaelsen Denmark 16 376 1.0× 304 1.6× 200 1.2× 87 0.6× 148 1.2× 36 687
Karina Eterovic United States 5 252 0.7× 207 1.1× 190 1.1× 70 0.5× 107 0.9× 6 545
Luisa Bellu Italy 13 465 1.3× 162 0.8× 158 0.9× 121 0.8× 218 1.8× 43 690
Kristin Alfaro-Munoz United States 11 410 1.1× 129 0.7× 137 0.8× 148 1.0× 129 1.1× 28 546
Michael Badruddoja United States 8 387 1.1× 238 1.2× 160 0.9× 114 0.7× 152 1.3× 20 681
Zhiyan Sun China 12 307 0.8× 150 0.8× 149 0.9× 280 1.8× 183 1.5× 28 579
Macarena I. de la Fuente United States 13 300 0.8× 153 0.8× 106 0.6× 76 0.5× 79 0.7× 36 510
Jose Carrillo United States 12 439 1.2× 176 0.9× 111 0.6× 249 1.6× 225 1.9× 41 795
Mario Caccese Italy 17 450 1.2× 253 1.3× 211 1.2× 114 0.7× 224 1.9× 70 883
Haihui Jiang China 17 515 1.4× 139 0.7× 177 1.0× 223 1.4× 163 1.4× 55 701

Countries citing papers authored by Thomas Urup

Since Specialization
Citations

This map shows the geographic impact of Thomas Urup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Urup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Urup more than expected).

Fields of papers citing papers by Thomas Urup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Urup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Urup. The network helps show where Thomas Urup may publish in the future.

Co-authorship network of co-authors of Thomas Urup

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Urup. A scholar is included among the top collaborators of Thomas Urup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Urup. Thomas Urup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urup, Thomas, Hans Skovgaard Poulsen, Kirsten Grunnet, et al.. (2024). Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023. Neuro-Oncology Practice. 12(1). 34–44. 3 indexed citations
2.
Carlsen, Jonathan Frederik, Vibeke Andrée Larsen, Jane Skjøth‐Rasmussen, et al.. (2024). Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy. Scientific Reports. 14(1). 10985–10985. 3 indexed citations
3.
Muhic, Aida, Søren Møller, Thomas Urup, et al.. (2023). The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients. Neuro-Oncology Advances. 5(1). vdad137–vdad137. 2 indexed citations
4.
Langer, Seppo W., et al.. (2023). A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis. Neuro-Oncology Advances. 5(1). vdad099–vdad099. 5 indexed citations
5.
Poulsen, Hans Skovgaard, et al.. (2022). Predicting survival of glioblastoma from automatic whole-brain and tumor segmentation of MR images. Scientific Reports. 12(1). 19744–19744. 14 indexed citations
6.
7.
Grunnet, Kirsten, Ib Jarle Christensen, Signe Regner Michaelsen, et al.. (2021). A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution. Frontiers in Oncology. 11. 597587–597587. 17 indexed citations
8.
Henriksen, Otto Mølby, Helle Broholm, Thomas Urup, et al.. (2019). Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET). Neuro-Oncology. 21(12). 1595–1606. 41 indexed citations
9.
Toft, Anders, Thomas Urup, Ib Jarle Christensen, et al.. (2018). Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan. Cancer Investigation. 36(2). 165–174. 4 indexed citations
10.
Michaelsen, Signe Regner, Thomas Urup, Lars Rønn Olsen, et al.. (2018). Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival. Journal of Neuro-Oncology. 137(3). 533–542. 30 indexed citations
11.
Michaelsen, Signe Regner, Kamilla E. Jensen, Helle Broholm, et al.. (2018). VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance. Neuro-Oncology. 20(11). 1462–1474. 59 indexed citations
12.
Urup, Thomas, Signe Regner Michaelsen, Kristoffer Vitting‐Seerup, et al.. (2017). Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients. BMC Cancer. 17(1). 278–278. 20 indexed citations
13.
Urup, Thomas, Signe Regner Michaelsen, Lars Rønn Olsen, et al.. (2016). Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients. Molecular Oncology. 10(8). 1160–1168. 22 indexed citations
14.
Campos, Benito, Lars Rønn Olsen, Thomas Urup, & Hans Skovgaard Poulsen. (2016). A comprehensive profile of recurrent glioblastoma. Oncogene. 35(45). 5819–5825. 164 indexed citations
15.
Nørgaard, Martin, Martin Bøgsted, Alexander Schmitz, et al.. (2016). Characterization of memory B cells from thymus and its impact for DLBCL classification. Experimental Hematology. 44(10). 982–990.e11. 2 indexed citations
16.
Urup, Thomas, Kirsten Grunnet, Ib Jarle Christensen, et al.. (2016). The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. 44(3). 373–381. 50 indexed citations
17.
Michaelsen, Signe Regner, Thomas Urup, Helle Broholm, et al.. (2015). 18F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma. PLoS ONE. 10(2). e0115315–e0115315. 7 indexed citations
18.
Poulsen, Hans Skovgaard, et al.. (2014). The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients. Cancer Management and Research. 6. 373–373. 33 indexed citations
19.
Urup, Thomas, Wojciech Pawlak, René Horsleben Petersen, et al.. (2013). Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study. British Journal of Cancer. 108(10). 1994–1997. 21 indexed citations
20.
Johnsen, Hans Erik, Malene Krag Kjeldsen, Thomas Urup, et al.. (2009). Cancer stem cells and the cellular hierarchy in haematological malignancies. European Journal of Cancer. 45. 194–201. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Signe Regner Michaelsen Breakdown of academic impact, for papers by Karina Eterovic Breakdown of academic impact, for papers by Luisa Bellu Breakdown of academic impact, for papers by Kristin Alfaro-Munoz Breakdown of academic impact, for papers by Michael Badruddoja Breakdown of academic impact, for papers by Zhiyan Sun Breakdown of academic impact, for papers by Macarena I. de la Fuente Breakdown of academic impact, for papers by Jose Carrillo Breakdown of academic impact, for papers by Mario Caccese Breakdown of academic impact, for papers by Haihui Jiang
Rankless by CCL
2026